LSG Lawsuit Status Guide
Menu
Active / Investigating

Bard Hernia Mesh

Plain-English guide to Bard hernia mesh lawsuits, MDL-2846 status, alleged chronic pain and revision surgery claims, evidence, deadlines, and settlement posture.

This guide is for general information only. It does not provide legal advice, does not create an attorney-client relationship, and case status can change.

Product Liability Primary injury: Chronic pain, infection, adhesions, recurrence, bowel complications, and revision surgery Updated June 29, 2026

Frequently Asked Questions

What is the Bard hernia mesh lawsuit about?

Bard hernia mesh lawsuits allege that certain polypropylene hernia mesh products were defectively designed or inadequately warned about and caused injuries such as chronic pain, infection, adhesions, recurrence, bowel complications, or revision surgery. Defendants dispute the allegations.

Where are federal Bard hernia mesh cases handled?

Federal Bard hernia mesh cases are coordinated in MDL-2846 before Judge Edmund A. Sargus, Jr. in the Southern District of Ohio.

How many Bard hernia mesh lawsuits are pending?

The JPML's June 1, 2026 report listed 23,573 pending actions in MDL-2846. The count can change monthly.

Is there a Bard hernia mesh settlement?

The litigation has involved settlement activity and individual case resolution, but no single court-approved public global settlement amount resolves every claim. Outcomes depend on product, injury, records, and litigation posture.

How much are Bard hernia mesh settlements worth?

There is no published per-person amount, and any figure presented online as an 'average hernia mesh payout' is speculation. Value in an individual case depends on product identification, injury severity, whether revision or removal surgery was required, causation proof, and state law. Early MDL bellwether trials produced mixed results — a defense verdict in the first (Johns v. Becton Dickinson) and plaintiff verdicts in later cases (for example, about $255,000 in Milanesi) — and past results do not predict any individual outcome. No amount is guaranteed.

Is the Bard hernia mesh lawsuit a class action?

No. Federal Bard hernia mesh cases are coordinated as multidistrict litigation (MDL-2846), where each plaintiff keeps an individual claim grouped for pretrial proceedings — unlike a class action, where one outcome binds the whole group.

When will the Bard hernia mesh lawsuit be settled?

There is no set settlement date. The MDL has worked through bellwether trials and ongoing case management, and although there has been settlement activity, no single public global settlement resolves every claim as of June 2026. Timing for any individual case depends on its trial track, evidence, and negotiations, and nothing is guaranteed.

Are other hernia mesh brands part of this lawsuit?

Not this MDL. This guide covers Bard/Davol polypropylene mesh (MDL-2846). Other manufacturers face separate litigation — for example, Covidien/Medtronic hernia mesh (MDL-3029, with a bellwether trial set for July 2026) and Atrium C-QUR (MDL-2753, which is winding down). Product identification matters because each manufacturer's cases proceed separately.

What proof may help a hernia mesh claim?

Helpful records may include implant records, device stickers, operative reports, revision surgery records, imaging reports, infection records, and records showing recurrence, adhesions, bowel complications, or chronic pain.

Do state deadlines matter?

Yes. Deadlines vary by state and may depend on implant date, complication date, discovery facts, revision date, wrongful-death issues, and other facts.

Related Lawsuits

Sources and Update Log

Last reviewed
June 29, 2026
Last updated
June 29, 2026

Case-level sources reviewed for this guide